Two Cos. to Study Safer Smallpox Vaccine

Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://www.lasvegassun.com/sunbin/stories/thrive/2003/feb/25/022506935.html

 

February 25, 2003

Two Cos. to Study Safer Smallpox Vaccine


ASSOCIATED PRESS

 

WASHINGTON (AP) - Two vaccine companies won $20 million in federal contracts Tuesday to speed development of a safer smallpox inoculation.

Acambis Inc. of Cambridge, Mass., and Denmark's Bavarian Nordic A/S are researching a smallpox vaccine that would be made with a modified version of the virus in today's shots.

Today, the only smallpox vaccine available isn't safe for people with weakened immune systems, and can even seriously harm some healthy people, because it's made with a live virus called vaccinia that can spread through the body. Scientists now are researching a modified strain of that virus that doesn't replicate inside cells, and therefore shouldn't pose such a risk.

The Department of Health and Human Services awarded the two companies three-year contracts that set timetables for them to produce doses of prototype vaccine, and perform safety testing first in animals and then in people.

--


 

Printable text version | Mail this to a friend

Las Vegas SUN main page

Problems or questions
Read our policy on privacy and cookies. Advertise on Vegas.com.
All contents © 1996 - 2003 Las Vegas Sun, Inc.
Nevada's Largest Website

 

  

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.